BIOTON S.A. (WSE:BIO)
3.505
+0.060 (1.74%)
Nov 4, 2026, 4:59 PM CET
BIOTON Market Cap
BIOTON has a market cap or net worth of 300.95 million as of November 4, 2026. It is the 26,986th most valuable company in the world and the 168th biggest in Poland. Its market cap has decreased by 18.11% in one year.
Market Cap
300.95M
Enterprise Value
366.96M
Revenue
257.23M
Global Rank
Country Rank
#168 Poland
PE Ratio
n/a
ChartMarket Cap Chart
Since July 1, 2005, BIOTON's market cap has decreased from 1.09B to 300.95M, a decrease of -72.47%. That is a compound annual growth rate of -5.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 300.95M | -9.20% |
| Dec 30, 2025 | 331.44M | 33.80% |
| Dec 30, 2024 | 247.72M | -19.19% |
| Dec 29, 2023 | 306.54M | 5.93% |
| Dec 30, 2022 | 289.36M | -19.47% |
| Dec 30, 2021 | 359.34M | -2.21% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 527.59M |
| Ryvu Therapeutics | 392.58M |
| Bioceltix | 387.26M |
| Captor Therapeutics Spolka Akcyjna | 336.73M |
| Synthaverse | 200.69M |
| Mabion | 127.68M |
| Poltreg | 126.02M |
| Molecure | 119.09M |